Yıldız Pehlivan, D., Yıldız, H., & Kaya, G. (2025). Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study. European Journal of Therapeutics, 31(1), 1–10. https://doi.org/10.58600/eurjther2520